New Mountain Capital and Wind Point Partners Recapitalize Ascensus Specialties
July 7, 2021
New Mountain Capital has led a recapitalization of Ascensus Specialties, with Wind Point Partners exiting its prior fund position while reinvesting alongside New Mountain through a special purpose vehicle anchored by Blackstone Strategic Partners. Ascensus, a Bellevue, Washington-based specialty chemicals manufacturer and global leader in borohydride, borane and specialty alcoholate reagents, will use the new capital to support R&D, product innovation and continued growth across pharmaceutical, microelectronics and other specialty end markets.
- Buyers
- New Mountain Capital, Wind Point Partners, Blackstone Strategic Partners
- Targets
- Ascensus Specialties
- Sellers
- Prior Wind Point Partners fund
- Industry
- Manufacturing
- Location
- Washington, United States
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
Ascensus Specialties Acquires Strem Chemicals
April 7, 2021
Manufacturing
Ascensus Specialties LLC, a Wind Point Partners-backed specialty chemicals platform, has completed the acquisition of Strem Chemicals, a Newburyport, Massachusetts-based maker of high-purity research-grade catalysts, ligands, organometallics and CVD/ALD precursors. The deal brings Strem's custom synthesis and cGMP manufacturing capabilities into the Ascensus platform to expand lab-to-commercial scale offerings and accelerate R&D and product development.
-
Stone Point Capital and GIC to Acquire Ascensus from Genstar, Aquiline and Atlas Merchant Capital
April 26, 2021
Financial Services
Funds managed by Stone Point Capital and GIC have agreed to acquire Ascensus from a private-equity group led by Genstar Capital, Aquiline Capital Partners, and Atlas Merchant Capital. Genstar and Aquiline will retain minority stakes; the transaction is expected to close in Q3 2021 pending regulatory approvals and customary conditions.
-
Atlas Merchant Capital-Led Group Acquires ~25% Stake in Ascensus
February 19, 2019
Financial Services
A group of new investors led by Atlas Merchant Capital LLC, including GIC, will acquire just under 25% of Ascensus from existing owners Genstar Capital and Aquiline Capital Partners. The minority investment is a growth-capital/secondary transaction to support Ascensus' continued growth and provide liquidity to existing sponsors; terms were not disclosed and the deal was expected to close in Q1 2019.
-
Ascensus Specialties (Wind Point) Acquires Callery, LLC
September 6, 2019
Manufacturing
Ascensus Specialties LLC, a Wind Point Partners–backed chemical producer, has signed a definitive agreement to acquire Callery, LLC, the global leader in boranes and specialty alcoholates. The add-on acquisition will combine complementary reagent chemistry capabilities to create a broader global reagents platform serving pharmaceutical, life sciences and specialty industrial end markets; terms were not disclosed.
-
New Mountain Capital Recapitalizes CenseoHealth and Advance Health
December 7, 2017
Healthcare Services
New Mountain Capital has acquired a majority ownership interest in CenseoHealth and Advance Health through a recapitalization announced December 7, 2017. The investment combines the two technology-enabled payer service providers to create a scale platform offering in-home health assessments, chronic care management and care coordination for health plans and providers across the United States.
-
New Mountain Capital Invests in Access Healthcare
January 14, 2025
Healthcare Services
Affiliates of New Mountain Capital have made a growth investment in Access Healthcare to support the company’s next phase of expansion. The capital will be used to advance AI and workflow automation, accelerate product development, and expand Access Healthcare’s revenue cycle management platform into new markets while the existing leadership team remains in place.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.